Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Bright

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Research in Social & Administrative Pharmacy : RSAP|March 17, 2024
Asynchronous consult report generation for pharmacogenomic clinical support: Time and motionDavid R Bright, Donald Klepser, Anna Langerveld
Currents in Pharmacy Teaching & Learning|December 1, 2018
Highlighting a gap in student pharmacist training: Intraprofessional education with pharmacy techniciansCortney M Mospan, David R Bright, Deeb Eid
Currents in Pharmacy Teaching & Learning|October 14, 2018
Interprofessional education through a telehealth team based learning exercise focused on pharmacogenomicsKelly M Quesnelle, David R Bright, Lisa A Salvati
Pharmacogenomics|September 15, 2021
Engaging pharmacogenomics in pain management and opioid selectionDavid R Bright, Natasha Petry, Eric Roath, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|June 2, 2011
Insulin pens vs. vials and syringes: differences in clinical and economic outcomesMichael D Bastian, Nicholas E Wolters, David R Bright
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|July 7, 2011
Insulin pens vs. vials and syringes: the pharmacist's role in individualizing therapyAmy N Honebrink, Chelsea R Peters, David R Bright
Pharmacogenomics and Personalized Medicine|May 27, 2021
Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-<i>CYP2C19</i> ExampleDavid F Kisor, Natasha J Petry, David R Bright
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|April 21, 2015
Pharmacogenetic considerations in the elderly patientDavid R Bright, Diane M Calinski, David F Kisor
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Pharmacy Technicians and Point of Care TestingMegan E Keller, Sarah E Kelling, David R Bright
Pharmacotherapy|June 28, 2017
Commentary: Should Pharmacogenomic Evidence Be Considered in Clinical Decision Making? Focus on Select Cardiovascular DrugsMichael B Bottorff, David R Bright, David F Kisor
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Research in Social & Administrative Pharmacy : RSAP|March 17, 2024
Asynchronous consult report generation for pharmacogenomic clinical support: Time and motionDavid R Bright, Donald Klepser, Anna Langerveld
Currents in Pharmacy Teaching & Learning|December 1, 2018
Highlighting a gap in student pharmacist training: Intraprofessional education with pharmacy techniciansCortney M Mospan, David R Bright, Deeb Eid
Currents in Pharmacy Teaching & Learning|October 14, 2018
Interprofessional education through a telehealth team based learning exercise focused on pharmacogenomicsKelly M Quesnelle, David R Bright, Lisa A Salvati
Pharmacogenomics|September 15, 2021
Engaging pharmacogenomics in pain management and opioid selectionDavid R Bright, Natasha Petry, Eric Roath, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|June 2, 2011
Insulin pens vs. vials and syringes: differences in clinical and economic outcomesMichael D Bastian, Nicholas E Wolters, David R Bright
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|July 7, 2011
Insulin pens vs. vials and syringes: the pharmacist's role in individualizing therapyAmy N Honebrink, Chelsea R Peters, David R Bright
Pharmacogenomics and Personalized Medicine|May 27, 2021
Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-<i>CYP2C19</i> ExampleDavid F Kisor, Natasha J Petry, David R Bright
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|April 21, 2015
Pharmacogenetic considerations in the elderly patientDavid R Bright, Diane M Calinski, David F Kisor
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Pharmacy Technicians and Point of Care TestingMegan E Keller, Sarah E Kelling, David R Bright
Pharmacotherapy|June 28, 2017
Commentary: Should Pharmacogenomic Evidence Be Considered in Clinical Decision Making? Focus on Select Cardiovascular DrugsMichael B Bottorff, David R Bright, David F Kisor
Pageof 4